DE602005018028D1 - Monoklonale antikörper mit spezifität für fetale erythroidzellen - Google Patents
Monoklonale antikörper mit spezifität für fetale erythroidzellenInfo
- Publication number
- DE602005018028D1 DE602005018028D1 DE602005018028T DE602005018028T DE602005018028D1 DE 602005018028 D1 DE602005018028 D1 DE 602005018028D1 DE 602005018028 T DE602005018028 T DE 602005018028T DE 602005018028 T DE602005018028 T DE 602005018028T DE 602005018028 D1 DE602005018028 D1 DE 602005018028D1
- Authority
- DE
- Germany
- Prior art keywords
- specificity
- cells
- monoclonal antibodies
- erythroid cells
- fetal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70582—CD71
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ecology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04007811 | 2004-03-31 | ||
| PCT/EP2005/003371 WO2005100401A2 (en) | 2004-03-31 | 2005-03-31 | Monoclonal antibodies with specificity for fetal erythroid cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005018028D1 true DE602005018028D1 (de) | 2010-01-14 |
Family
ID=35150543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005018028T Active DE602005018028D1 (de) | 2004-03-31 | 2005-03-31 | Monoklonale antikörper mit spezifität für fetale erythroidzellen |
Country Status (9)
| Country | Link |
|---|---|
| US (6) | US7858757B2 (de) |
| EP (1) | EP1732951B1 (de) |
| JP (1) | JP4756032B2 (de) |
| AT (1) | ATE450549T1 (de) |
| AU (1) | AU2005233254B2 (de) |
| CA (1) | CA2561830C (de) |
| DE (1) | DE602005018028D1 (de) |
| ES (1) | ES2337702T3 (de) |
| WO (1) | WO2005100401A2 (de) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2337702T3 (es) * | 2004-03-31 | 2010-04-28 | Adnagen Ag | Anticuerpos monoclonales con especificidad por eritrocitos fetales. |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
| DE102006062619B4 (de) * | 2006-12-29 | 2012-04-26 | Medion Diagnostics Ag | Verfahren zur Bestimmung von minoren Zellpopulationen in heterogenen Zellpopulationen |
| AU2009279734A1 (en) | 2008-08-04 | 2010-02-11 | Natera, Inc. | Methods for allele calling and ploidy calling |
| EP2854056A3 (de) | 2009-09-30 | 2015-06-03 | Natera, Inc. | Verfahren zur nichtinvasiven pränatalen Ploidiezuordnung |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2854058A3 (de) | 2010-05-18 | 2015-10-28 | Natera, Inc. | Verfahren zur nichtinvasiven pränatalen Ploidiezuordnung |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| BR112013013083A2 (pt) | 2010-11-30 | 2016-12-13 | Genentech Inc | métodos para transportar um composto, para aumentar exposição do cns a um composto, para diminuir a depuração de um composto, para aumentar a retenção no cns de um composto, para otimizar a farmacocinética, para tratar um distúrbio neurológico em um mamífero, para desenvolver um anticorpo, anticorpo, fragmento de anticorpo, anticorpo multiespecífico e uso de um anticorpo |
| BR112013016193B1 (pt) | 2010-12-22 | 2019-10-22 | Natera Inc | método ex vivo para determinar se um suposto pai é o pai biológico de um feto que está em gestação em uma gestante e relatório |
| AU2011358564B9 (en) | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
| US10466160B2 (en) | 2011-08-01 | 2019-11-05 | Celsee Diagnostics, Inc. | System and method for retrieving and analyzing particles |
| US9174216B2 (en) | 2013-03-13 | 2015-11-03 | DeNovo Science, Inc. | System for capturing and analyzing cells |
| US9404864B2 (en) | 2013-03-13 | 2016-08-02 | Denovo Sciences, Inc. | System for imaging captured cells |
| EP2739587B1 (de) | 2011-08-01 | 2020-05-27 | Denovo Sciences | Zellerfassungssystem |
| US20130122492A1 (en) * | 2011-11-14 | 2013-05-16 | Kellbenx Inc. | Detection, isolation and analysis of rare cells in biological fluids |
| US10058306B2 (en) | 2012-06-22 | 2018-08-28 | Preprogen, LLC | Method for obtaining fetal cells and fetal cellular components |
| US9752181B2 (en) | 2013-01-26 | 2017-09-05 | Denovo Sciences, Inc. | System and method for capturing and analyzing cells |
| US9707562B2 (en) | 2013-03-13 | 2017-07-18 | Denovo Sciences, Inc. | System for capturing and analyzing cells |
| US9856535B2 (en) | 2013-05-31 | 2018-01-02 | Denovo Sciences, Inc. | System for isolating cells |
| US10391490B2 (en) | 2013-05-31 | 2019-08-27 | Celsee Diagnostics, Inc. | System and method for isolating and analyzing cells |
| US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
| US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| WO2015048535A1 (en) | 2013-09-27 | 2015-04-02 | Natera, Inc. | Prenatal diagnostic resting standards |
| EP3561075A1 (de) | 2014-04-21 | 2019-10-30 | Natera, Inc. | Nachweis von mutationen in tumorbiopsien und in zellfreie proben |
| US20160130553A1 (en) * | 2014-05-15 | 2016-05-12 | Kellbenx Incorporated | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING |
| EP3489691A1 (de) | 2014-05-15 | 2019-05-29 | Kellbenx Inc. | Herstellung fetaler nukleierter erythrozyten für diagnostische tests |
| WO2016021309A1 (ja) * | 2014-08-05 | 2016-02-11 | 富士フイルム株式会社 | 有核赤血球の選別方法 |
| US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
| US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| JP6234542B1 (ja) | 2016-12-27 | 2017-11-22 | 株式会社 ＴＬ Ｇｅｎｏｍｉｃｓ | 胎児細胞由来染色体ｄｎａの取得方法 |
| CA3049139A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
| EP3651903A4 (de) | 2017-08-29 | 2021-06-16 | Bio-Rad Laboratories, Inc. | System und verfahren zur isolierung und analyse von zellen |
| CN111247427B (zh) | 2017-10-19 | 2022-02-01 | Tl基因体科技株式会社 | 细胞分类芯片 |
| US10946380B2 (en) * | 2018-01-19 | 2021-03-16 | International Business Machines Corporation | Microfluidic chips for particle purification and fractionation |
| US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| US10633693B1 (en) | 2019-04-16 | 2020-04-28 | Celsee Diagnostics, Inc. | System and method for leakage control in a particle capture system |
| EP3963337A1 (de) | 2019-05-02 | 2022-03-09 | KellBenx Inc. | Filtrationsbasierte verfahren zur vorbereitung fötaler nukleierter roter blutkörperchen (nrbcs) für diagnostische tests |
| CN114072490A (zh) | 2019-05-07 | 2022-02-18 | 伯乐实验室有限公司 | 用于自动化的单细胞加工的系统和方法 |
| US11273439B2 (en) | 2019-05-07 | 2022-03-15 | Bio-Rad Laboratories, Inc. | System and method for target material retrieval from microwells |
| US11724256B2 (en) | 2019-06-14 | 2023-08-15 | Bio-Rad Laboratories, Inc. | System and method for automated single cell processing and analyses |
| US11504719B2 (en) | 2020-03-12 | 2022-11-22 | Bio-Rad Laboratories, Inc. | System and method for receiving and delivering a fluid for sample processing |
| US11827702B2 (en) | 2021-09-01 | 2023-11-28 | Biogen Ma Inc. | Anti-transferrin receptor antibodies and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10035433C2 (de) * | 2000-07-20 | 2002-07-18 | Tuma Wolfgang | Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben |
| ITRM20010322A1 (it) | 2001-06-08 | 2002-12-09 | Consiglio Nazionale Ricerche | Metodo non ivasivo su sangue materno per lo screening e la diagnosi di aneuploidie fetali. |
| ES2337702T3 (es) * | 2004-03-31 | 2010-04-28 | Adnagen Ag | Anticuerpos monoclonales con especificidad por eritrocitos fetales. |
-
2005
- 2005-03-31 ES ES05736009T patent/ES2337702T3/es active Active
- 2005-03-31 JP JP2007505500A patent/JP4756032B2/ja active Active
- 2005-03-31 DE DE602005018028T patent/DE602005018028D1/de active Active
- 2005-03-31 WO PCT/EP2005/003371 patent/WO2005100401A2/en active Application Filing
- 2005-03-31 CA CA2561830A patent/CA2561830C/en active Active
- 2005-03-31 AT AT05736009T patent/ATE450549T1/de active
- 2005-03-31 EP EP05736009A patent/EP1732951B1/de active Active
- 2005-03-31 AU AU2005233254A patent/AU2005233254B2/en active Active
- 2005-03-31 US US10/599,512 patent/US7858757B2/en active Active
-
2010
- 2010-12-28 US US12/979,535 patent/US8536312B2/en active Active
-
2013
- 2013-09-16 US US14/028,027 patent/US9194871B2/en active Active
-
2015
- 2015-08-13 US US14/825,516 patent/US20160039932A1/en not_active Abandoned
- 2015-10-14 US US14/882,995 patent/US9453841B2/en active Active
-
2022
- 2022-11-18 US US17/989,895 patent/US20230324383A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20160039932A1 (en) | 2016-02-11 |
| CA2561830A1 (en) | 2005-10-27 |
| ATE450549T1 (de) | 2009-12-15 |
| JP4756032B2 (ja) | 2011-08-24 |
| US20140154704A1 (en) | 2014-06-05 |
| EP1732951B1 (de) | 2009-12-02 |
| US8536312B2 (en) | 2013-09-17 |
| US9194871B2 (en) | 2015-11-24 |
| JP2007530629A (ja) | 2007-11-01 |
| WO2005100401A2 (en) | 2005-10-27 |
| ES2337702T3 (es) | 2010-04-28 |
| US20110129916A1 (en) | 2011-06-02 |
| US20230324383A1 (en) | 2023-10-12 |
| US7858757B2 (en) | 2010-12-28 |
| EP1732951A2 (de) | 2006-12-20 |
| US9453841B2 (en) | 2016-09-27 |
| AU2005233254A1 (en) | 2005-10-27 |
| CA2561830C (en) | 2013-05-21 |
| AU2005233254B2 (en) | 2011-11-24 |
| WO2005100401A3 (en) | 2006-06-15 |
| US20160084837A1 (en) | 2016-03-24 |
| US20070275418A1 (en) | 2007-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE450549T1 (de) | Monoklonale antikörper mit spezifität für fetale erythroidzellen | |
| ATE528648T1 (de) | Verfahren zum nachweis antikörper-herstellender zellen | |
| NZ623706A (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof | |
| DK1881064T3 (da) | HCV-anti-kerne monoklonalt antistof | |
| TW200616662A (en) | Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates | |
| EA200971114A1 (ru) | Определение антигенов, расположенных на эритроцитах, и антиэритроцитарных антител | |
| MY189968A (en) | Monoclonal antibody, and immunoassay using the same | |
| ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
| WO2008122793A3 (en) | Blood group antibody screening | |
| ATE277083T1 (de) | Antikörper, die spezifisch für fullerene sind | |
| WO2008025964A3 (en) | Antibodies to an epitope of agr2. assays and hybridomas | |
| WO2004106385A3 (en) | Monoclonal antibodies specific for buprenorphine and metabolites thereof | |
| WO2006075142A3 (en) | FORMS OF FACTOR XIIa | |
| EP1072888A3 (de) | Immunoassay-Verfahren und -Reagens für HIV-1p24-Antigen | |
| WO2005114203A3 (en) | Dominant b cell epitopes and methods of making and using thereof | |
| EP1879029B8 (de) | Immunnachweiskit in verbindung mit neuroglobin-enzym sowie verwendung davon | |
| AU2003283240A1 (en) | Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells | |
| WO2006044888A3 (en) | Reagents for urine-based immunological assays | |
| WO2007011698A3 (en) | Humanized antibody conjugates and related methods, assays, reagents, and kits | |
| WO2006060188A3 (en) | Anti-tenascin monoclonal antibody immunoassays and diagnostic kits | |
| WO2010053772A3 (en) | Disease-associated antigens and methods of use thereof | |
| EP1359161A3 (de) | Monoklonaler Antikörper, der spezifische gegen tartratbeständige Säurephosphatase 5b gerichtet ist und dessen Verwendung | |
| MX2022014580A (es) | Ensayo de multiplex doble para multiples isotipos de inmunoglobulina. | |
| BR0204612A (pt) | Anticorpos monoclonais antinúcleo de hcv | |
| WO2009035357A3 (en) | Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |